EA025483B1 - Внутривенный способ лечения сезонного гриппа - Google Patents

Внутривенный способ лечения сезонного гриппа Download PDF

Info

Publication number
EA025483B1
EA025483B1 EA200870263A EA200870263A EA025483B1 EA 025483 B1 EA025483 B1 EA 025483B1 EA 200870263 A EA200870263 A EA 200870263A EA 200870263 A EA200870263 A EA 200870263A EA 025483 B1 EA025483 B1 EA 025483B1
Authority
EA
Eurasian Patent Office
Prior art keywords
peramivir
acceptable salt
compound
pharmaceutically acceptable
formula
Prior art date
Application number
EA200870263A
Other languages
English (en)
Russian (ru)
Other versions
EA200870263A1 (ru
Inventor
Ярлагадда Судхакара Бабу
Пооран Чанд
Шанта Бантиа
Шейн Арнольд
Джон Майкл Килпатрик
Original Assignee
Байокрист Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA025483(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/fr
Application filed by Байокрист Фармасьютикалз, Инк. filed Critical Байокрист Фармасьютикалз, Инк.
Publication of EA200870263A1 publication Critical patent/EA200870263A1/ru
Publication of EA025483B1 publication Critical patent/EA025483B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EA200870263A 2006-02-13 2007-02-12 Внутривенный способ лечения сезонного гриппа EA025483B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
PCT/US2006/013535 WO2007117241A1 (fr) 2006-04-12 2006-04-12 Traitements antiviraux intramusculaires
PCT/US2007/003755 WO2007095218A1 (fr) 2006-02-13 2007-02-12 Traitements antiviraux intraveineux

Publications (2)

Publication Number Publication Date
EA200870263A1 EA200870263A1 (ru) 2009-06-30
EA025483B1 true EA025483B1 (ru) 2016-12-30

Family

ID=38169715

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870263A EA025483B1 (ru) 2006-02-13 2007-02-12 Внутривенный способ лечения сезонного гриппа

Country Status (11)

Country Link
EP (1) EP1986626A1 (fr)
JP (3) JP2009538822A (fr)
KR (9) KR20230003248A (fr)
AU (2) AU2007215156A1 (fr)
BR (1) BRPI0707769A2 (fr)
CA (1) CA2642260C (fr)
EA (1) EA025483B1 (fr)
HK (1) HK1212250A1 (fr)
MX (2) MX2020002008A (fr)
MY (1) MY166063A (fr)
WO (1) WO2007095218A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095218A1 (fr) * 2006-02-13 2007-08-23 Biocryst Pharmaceuticals, Inc. Traitements antiviraux intraveineux
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
KR20220033561A (ko) 2020-09-07 2022-03-17 주식회사 경보제약 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097792A2 (fr) * 2000-06-22 2001-12-27 Glaxosmithkline K K Medicaments
US6562861B1 (en) * 1997-12-17 2003-05-13 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000016669A (ko) * 1996-06-14 2000-03-25 몽고메리 죤 에이 뉴라미니다제 저해제로 유용한 치환된 시클로펜탄 화합물
WO2007095218A1 (fr) * 2006-02-13 2007-08-23 Biocryst Pharmaceuticals, Inc. Traitements antiviraux intraveineux

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562861B1 (en) * 1997-12-17 2003-05-13 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
WO2001097792A2 (fr) * 2000-06-22 2001-12-27 Glaxosmithkline K K Medicaments

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BANTIA, S. ARNOLD, C.S. PARKER, C.D. UPSHAW, R. CHAND, P.: "Anti-influenza virus activity of peramivir in mice with single intramuscular injection", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 69, no. 1, 1 January 2006 (2006-01-01), NL, pages 39 - 45, XP005212462, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2005.10.002 *
CHAND, P. BANTIA, S. KOTIAN, P.L. EL-KATTAN, Y. LIN, T.H. BABU, Y.S.: "Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 13, no. 12, 2 June 2005 (2005-06-02), GB, pages 4071 - 4077, XP004903742, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2005.03.048 *
SORBERA L. A., ET AL.: "ANTI-INFLUENZA NEURAMINIDASE (SIALIDASE) INHIBITOR.", DRUGS OF THE FUTURE, PROUS SCIENCE, ES, vol. 25., no. 03., 1 January 2000 (2000-01-01), ES, pages 249 - 251., XP000940977, ISSN: 0377-8282, DOI: 10.1358/dof.2000.025.03.565302 *

Also Published As

Publication number Publication date
KR20210076189A (ko) 2021-06-23
JP2015180695A (ja) 2015-10-15
CA2642260C (fr) 2016-08-09
KR20160129105A (ko) 2016-11-08
CA2642260A1 (fr) 2007-08-23
JP2013256527A (ja) 2013-12-26
WO2007095218A1 (fr) 2007-08-23
BRPI0707769A2 (pt) 2011-05-10
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
EA200870263A1 (ru) 2009-06-30
MY166063A (en) 2018-05-23
EP1986626A1 (fr) 2008-11-05
KR20230003248A (ko) 2023-01-05
JP6073202B2 (ja) 2017-02-01
MX2008010394A (es) 2009-01-12
KR20080096829A (ko) 2008-11-03
KR102323339B1 (ko) 2021-11-08
KR102267754B1 (ko) 2021-06-23
KR20140132778A (ko) 2014-11-18
MX2020002008A (es) 2020-07-13
KR101992585B9 (ko) 2022-09-20
KR20200143519A (ko) 2020-12-23
KR102475176B1 (ko) 2022-12-07
KR20210135632A (ko) 2021-11-15
KR101992585B1 (ko) 2019-06-25
HK1212250A1 (en) 2016-06-10
AU2007215156A1 (en) 2007-08-23
KR20190072681A (ko) 2019-06-25
KR102194015B1 (ko) 2020-12-22
KR20180024027A (ko) 2018-03-07
JP2009538822A (ja) 2009-11-12

Similar Documents

Publication Publication Date Title
ES2432164T3 (es) Composición estabilizada que comprende al menos un compuesto adrenérgico
US11738025B2 (en) Method for treating coronavirus infections
US20080269347A1 (en) Epinephrine formulations
EP2635269B1 (fr) Composition combinée
CN111163764A (zh) L-肾上腺素的稳定化可注射药物组合物
JP2023061957A (ja) 抑うつ障害の処置
KR102656841B1 (ko) 레파뮬린의 주사가능한 약제학적 제형
JP6073202B2 (ja) 静脈におけるウイルスの治療
JP2009538822A5 (fr)
ES2272297T3 (es) Medicamento destinado al tratamiento de neuropatias.
JP2009533428A (ja) 筋肉内抗ウイルス処置
US20230285434A1 (en) Method for treating arenaviridae infections
JPH11511479A (ja) １，２，４−ベンゾトリアジンオキシド製剤
WO2022046976A1 (fr) Formulation d'injection d'épinéphrine ayant une très faible concentration d'épinéphrine et une faible quantité d'impuretés pendant sa durée de conservation
AU2016262644A1 (en) Intravenous antiviral treatments
WO2020025986A1 (fr) Combinaison injectable de diclofénac sodique et de thiocolchicoside